Tyrosine Kinase Inhibition in a Lung Adenocarcinoma Patient With Dual G719S and S768I EGFR Mutations

被引：1

作者：

Zaemes, Jacob ^{[1
]}

Hall, Richard D. ^{[1
]}

Gentzler, Ryan D. ^{[1
]}

机构：

[1] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 08期

关键词：

D O I：

10.1016/j.jtho.2018.03.021

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E136 / E137

页数：3

共 50 条

[31] EGFR mutations in patients with lung adenocarcinoma in southwest China: are G719S/A and L861Q more likely detected in tumors derived from smokers?
Wang, Qiushi
Mou, Jianghong
Yang, Xin
He, Yong
Li, Zengpeng
Luo, Qingya
Li, Yanqing
Lin, Li
Ma, Yu
Xiao, Hualiang
[J]. LUNG CANCER-TARGETS AND THERAPY, 2013, 4 : 27 - 33
[32] Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan
Ping-Chih Hsu
Suey-Haur Lee
Li-Chung Chiu
Chung-Shu Lee
Chiao-En Wu
Scott Chih-Hsi Kuo
Jia-Shiuan Ju
Allen Chung-Cheng Huang
Shih-Hong Li
Ho-Wen Ko
Cheng-Ta Yang
Chin-Chou Wang
[J]. Targeted Oncology, 2023, 18 : 195 - 207
[33] Afatinib in Untreated Stage IIIB/IV Lung Adenocarcinoma with Major Uncommon Epidermal Growth Factor Receptor (EGFR) Mutations (G719X/L861Q/S768I): A Multicenter Observational Study in Taiwan
Hsu, Ping-Chih
Lee, Suey-Haur
Chiu, Li-Chung
Lee, Chung-Shu
Wu, Chiao-En
Kuo, Scott Chih-Hsi
Ju, Jia-Shiuan
Huang, Allen Chung-Cheng
Li, Shih-Hong
Ko, Ho-Wen
Yang, Cheng-Ta
Wang, Chin-Chou
[J]. TARGETED ONCOLOGY, 2023, 18 (02) : 195 - 207
[34] Successful treatment of an osimertinib-resistant lung adenocarcinoma with an exon 18 EGFR mutation (G719S) with afatinib plus bevacizumab
Motohiro Tamiya
Kei Kunimasa
Kazumi Nishino
Shingo Matsumoto
Hayato Kawachi
Kika Kuno
Takako Inoue
Hanako Kuhara
Fumio Imamura
Koichi Goto
Toru Kumagai
[J]. Investigational New Drugs, 2021, 39 : 232 - 236
[35] Prolonged response to first-generation tyrosine kinase inhibitor in a metastatic non-small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
Do, Kien Hung
Le, Duc Thanh
Nguyen, Tai Van
Do, Tu Anh
Nguyen, Chu Van
[J]. RESPIROLOGY CASE REPORTS, 2023, 11 (05):
[36] Unique characteristics of G719X and S768I compound double mutations of epidermal growth factor receptor (EGFR) gene in lung cancer of coal-producing areas of East Yunnan in Southwestern China
Jun-Ling Wang
Yu-Dong Fu
Yan-Hong Gao
Xiu-Ping Li
Qian Xiong
Rui Li
Bo Hou
Ruo-Shan Huang
Jun-Feng Wang
Jian-Kun Zhang
Jia-Ling Lv
Chao Zhang
Hong-Wei Li
[J]. Genes and Environment, 44
[37] Exceptional Response to Aumolertinib in an Advanced NSCLC Patient With Rare EGFR Exon20 V774M and S768I Mutations
Tao, T.
[J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S655 - S655
[38] Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I
Pang, Lan-Lan
Gan, Jia-Di
Tan, Jia-Rong
Huang, Yi-Hua
Liao, Jun
Liang, Wei-Ting
Deng, Peng-Bo
Fang, Wen-Feng
[J]. CANCER, 2022, 128 (21) : 3804 - 3814
[39] Primary lung adenocarcinoma occurring in a PTEN related syndrome (Cowden's disease): Routine EGFR sequencing also highlights two rare somatic mutations S768I and V769L
Boespflug, Amelie
Couraud, Sebastien
Bringuier, Pierre-Paul
Isaac, Sylvie
Geriniere, Laurence
Perrot, Emilie
Edery, Patrick
Durieu, Isabelle
Souquet, Pierre-Jean
[J]. LUNG CANCER, 2013, 79 (03) : 318 - 320
[40] Synchronous occurrence of squamous-cell carcinoma "transformation" and EGFR exon 20 S768I mutation as a novel mechanism of resistance in EGFR-mutated lung adenocarcinoma
Longo, Lucia
Mengoli, Maria Cecilia
Bertolini, Federica
Bettelli, Stefania
Manfredini, Samantha
Rossi, Giulio
[J]. LUNG CANCER, 2017, 103 : 24 - 26

← 1 2 3 4 5 →